Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.71 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.71 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.71 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.71 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.71 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 8/20 | 0.44 |
| ▸ | CDC25A | P30304 | 6/20 | 0.44 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | EPAS1 | Q99814 | 5/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.39 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.38 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.38 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.38 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.38 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.38 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6784018 | 1.00 | CHRNB2 (0.71) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| SCHEMBL6784016 | 1.00 | CHRNB2 (0.71) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| SCHEMBL13692692 | 1.00 | CHRNB2 (0.71) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Polygodial SCHEMBL258239 | 0.83 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Epipolygodial SCHEMBL21322435 | 0.83 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Epipolygodial SCHEMBL13855685 | 0.83 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Epipolygodial SCHEMBL29370854 | 0.83 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Polygodial SCHEMBL21633831 | 0.83 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| SCHEMBL13903721 | 0.81 | CHRNB2 (0.66) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| SCHEMBL18583216 | 0.76 | CHRNB2 (0.70) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658802-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | Firmenich SA (CH) | 2025-12-10 | — | — | EP | claimed |
| WO-2024160757-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | FIRMENICH SA (CH) | 2024-08-08 | — | — | WO | claimed |
| EP-4658802-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | Firmenich SA (CH) | 2025-12-10 | — | — | EP | disclosed |
| US-20250288553-A1 | Antimicrobial Compositions and Uses for Treatment of Clostridioides difficile, Mycobacterium tuberculosis, and Enterococcus faecalis Infection | THE UNIVERSITY OF TOLEDO | 2025-09-18 | — | — | US | disclosed |
| WO-2024160757-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | FIRMENICH SA (CH) | 2024-08-08 | — | — | WO | disclosed |
| CN-110691850-B | Method for producing patchoulol and/or drimenol | 弗门尼舍有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-11932894-B2 | Method for producing albicanol and/or drimenol | FIRMENICH SA (CH) | 2024-03-19 | — | — | US | disclosed |
| WO-2023215619-A2 | ANTIMICROBIAL COMPOSITIONS AND USES FOR TREATMENT OF CLOSTRIDIOIDES DIFFICILE, MYCOBACTERIUM TUBERCULOSIS, AND ENTEROCOCCUS FAECALIS INFECTION | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-11773414-B2 | Sesquiterpene synthases for production of drimenol and mixtures thereof | FIRMENICH SA (CH) | 2023-10-03 | — | — | US | disclosed |
| CN-115160159-B | Halichonin B analogue, preparation method thereof and application thereof in preparing agricultural bactericide | 贵州大学 | 2023-06-16 | — | — | CN | disclosed |
| EP-3619303-B1 | SESQUITERPENE SYNTHASES FOR PRODUCTION OF DRIMENOL AND MIXTURES THEREOF | FIRMENICH & CIE (CH) | 2023-06-07 | — | — | EP | disclosed |
| US-20230148463-A9 | METHOD FOR PRODUCING ALBICANOL AND/OR DRIMENOL | FIRMENICH SA (CH) | 2023-05-11 | — | — | US | disclosed |
| US-20220186265-A1 | METHOD FOR PRODUCING ALBICANOL AND/OR DRIMENOL | FIRMENICH & CIE (CH) | 2022-06-16 | — | — | US | disclosed |
| US-11293037-B2 | Method for producing albicanol and/or drimenol | FIRMENICH SA (CH) | 2022-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250288553-A1 | Antimicrobial Compositions and Uses for Treatment of Clostridioides difficile, Mycobacterium tuberculosis, and Enterococcus faecalis Infection | VDR, CYP2R1, PTH1R | CHRNB2 2455/4885CHRNB4 2614/4885CHRNA3 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.